Equifax (EFX) Stock Forecast & Price Target

Q: What analysts cover Equifax?

Equifax has been rated by research analysts at Barclays , BMO Capital Markets , BNP Paribas Exane , Citigroup , Credit Suisse Group , Deutsche Bank Aktiengesellschaft , JPMorgan Chase & Co. , Morgan Stanley , Needham & Company LLC , Robert W. Baird , Rothschild & Co Redburn , Royal Bank Of Canada , The Goldman Sachs Group , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$145.69 +0.15 (+0.10%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$145.52 -0.16 (-0.11%)

As of 10/9/2026 07:30 PM Eastern

Compare

Equifax - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 21 Analyst Ratings

Sell
0

Hold
6

Buy
15

Based on 21 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 6 have given a hold rating, and 15 have given a buy rating for EFX.

Consensus Price Target

$206.90
42.01% Upside

According to the 21 analysts' twelve-month price targets for Equifax, the average price target is $206.90. The highest price target for EFX is $266.00, while the lowest price target for EFX is $148.00. The average price target represents a forecasted upside of 42.01% from the current price of $145.69.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EFX Analyst Ratings Over Time

Type	Current Forecast 10/10/25 to 10/10/26	1 Month Ago 9/10/25 to 9/10/26	3 Months Ago 7/12/25 to 7/12/26	1 Year Ago 10/10/24 to 10/10/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	13 Buy rating(s)	12 Buy rating(s)
Hold	6 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)	7 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$206.90	$215.16	$222.00	$282.47
Forecasted Upside	42.01% Upside	28.17% Upside	33.36% Upside	22.75% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Equifax Stock vs. The Competition

Type	Equifax	Industrials Companies	Broader Market
Consensus Rating Score	2.71	2.31	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	42.01% Upside	120.42% Upside	19.61% Upside
News Sentiment Rating	Neutral News See Recent EFX News	Neutral News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/2/2026	The Goldman Sachs Group 3 of 5 stars	George Tong 1 of 5 stars	Set Target		$148.00	+3.62%
10/2/2026	Barclays 3 of 5 stars	Manav Patnaik 1 of 5 stars	Lower Target	Equal Weight	$200.00 ➝ $155.00	+11.01%
9/30/2026	Credit Suisse Group 1 of 5 stars		Set Target		$160.00	+13.80%
9/30/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Griffin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Perform	$179.00 ➝ $160.00	+16.06%
9/22/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$212.00 ➝ $200.00	+25.87%
9/16/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
8/21/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simon Clinch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$214.00 ➝ $235.00	+22.27%
8/13/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Sell (D+) ➝ Hold (C-)
7/22/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Buy	$217.00 ➝ $208.00	+22.62%
7/22/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Toni Kaplan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$243.00 ➝ $225.00	+30.64%
Get the Latest News and Ratings for EFX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Equifax and its competitors with MarketBeat's FREE daily newsletter.
7/22/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Meuler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$245.00 ➝ $232.00	+34.70%
7/22/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashish Sabadra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$222.00 ➝ $194.00	+12.64%
7/22/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$238.00 ➝ $220.00	+18.25%
7/22/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Neutral	$185.00 ➝ $190.00	+2.12%
7/22/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$230.00 ➝ $210.00	+12.87%
7/8/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin McVeigh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$220.00	+31.12%
7/2/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Kennedy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$222.00 ➝ $210.00	+25.37%
5/19/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$250.00 ➝ $225.00	+40.19%
4/24/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$220.00 ➝ $200.00	+16.12%
3/2/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold
2/5/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shlomo Rosenbaum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$253.00 ➝ $235.00	+26.13%
1/12/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rayna Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$271.00 ➝ $266.00	+19.81%
2/18/2025	Gordon Haskett Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chuck Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
2/7/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
12/12/2024	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Wurtzel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:23 AM ET.

Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 8, 2026. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

Here are some ways that investors could benefit from investing in Equifax Inc.:

Equifax Inc. is currently trading at $145.38, which is significantly below the average analyst price target of $213.95, suggesting substantial potential upside for investors who believe the market has overreacted to recent negative news.
The company is driving industry adoption of its VantageScore 4.0 model, with nearly 2,000 mortgage lenders implementing this modern, alternative data-driven scoring model, which positions Equifax Inc. to capture significant market share in the evolving credit scoring landscape.
Equifax Inc. has introduced the Mortgage Score Select solution, which allows lenders to choose which score goes on the file and repull files for just $1, enhancing operational efficiency and cost savings for clients while strengthening Equifax Inc.'s value proposition in the mortgage sector.
Recent earnings reports show strong performance, with Q2 2026 revenue of $1.65 billion, exceeding consensus estimates, and a 14.3% year-over-year revenue growth, indicating robust demand for Equifax Inc.'s data and analytics services despite macroeconomic headwinds.
Equifax Inc. maintains a solid dividend yield of 1.57%, providing income stability for investors, while its beta of 1.35 suggests it may offer higher returns than the broader market during periods of economic recovery.

Equifax
Bear Case

Investors should be bearish about investing in Equifax Inc. for these reasons:

Equifax Inc. has recently hit a 52-week low of $137.01, reflecting significant downward pressure on the stock price due to concerns about mortgage weakness and uncertainty in the credit score transition, which may deter risk-averse investors.
Multiple major brokerages, including BMO Capital Markets and Goldman Sachs, have recently lowered their price targets for Equifax Inc., with BMO cutting its target from $179.00 to $160.00 and Goldman Sachs reducing its target from $171.00 to $148.00, indicating a bearish outlook from Wall Street analysts.
Insider selling activity has been notable, with CEO Mark Begor and other executives selling a total of 75,582 shares in the past six months, which may signal a lack of confidence in the company's near-term prospects among its leadership.
Equifax Inc. faces regulatory and industry changes in mortgage credit scoring, with the FHFA expanding VantageScore 4.0 availability, which could disrupt the traditional credit bureau ecosystem and impact Equifax Inc.'s revenue streams in the long term.
The company's full-year 2026 revenue guidance of $6.710 billion to $6.780 billion suggests that growth is being managed through a challenging market environment, with potential headwinds from weaker mortgage originations affecting its Workforce Solutions and USIS segments.

EFX Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $206.90, with a high forecast of $266.00 and a low forecast of $148.00.

21 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last twelve months. There are currently 6 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 42.01% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 3 upgrades and 1 downgrade by analysts.

Equifax has been rated by research analysts at Barclays, BMO Capital Markets, BNP Paribas Exane, Citigroup, Credit Suisse Group, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Robert W. Baird, Rothschild & Co Redburn, Royal Bank Of Canada, The Goldman Sachs Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Equifax more than other "industrials" companies. The consensus rating for Equifax is Moderate Buy while the average consensus rating for "industrials" companies is Hold. Learn more on how EFX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Equifax Recommendations

MarketBeat monitors more than a dozen sources for Equifax analyst ratings, with the most recent rating issued on 10/2/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equifax (EFX) Stock Forecast & Price Target